Auris Medical
About us Inner ear disorders Cochlear therapies News  
 
 
Welcome to Auris Medical

Auris Medical is dedicated to the development of novel
pharmaceutical therapies to prevent or treat severe
inner ear disorders.

 

We aim to protect people against hearing loss from various
sources and to finally bring relief to people suffering
from tinnitus.

 

 

Ongoing clinical trials:

 

Efficacy and Safety of AM-101 in the Treatment
of Acute Peripheral Tinnitus (TACTT3)

 

  Austria

  France

  Germany

  Hungary

  United Kingdom

 

Efficacy and Safety of AM-101 in the Treatment
of Acute Peripheral Tinnitus (TACTT2)

 

  USA

 

Contact Jobs Impressum Deutsch
Latest News
 March 31, 2014

Published analysis confirms positive results from Auris Medical’s phase IIb study with AM-101 in treatment of acute inner ear tinnitus
>

 March 10, 2014

Auris Medical announces enrollment of first patient in North American Phase 3 study of AM-101 in treatment of acute peripheral tinnitus
>